Anti-PCYXL/ PCYOX1L functional antibody

Anti-PCYXL/ PCYOX1L functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PCYOX1L/PCYOX1L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1176-Ab-1/ GM-Tg-hg-SE1176-Ab-2Anti-Human PCYOX1L monoclonal antibodyHuman
GM-Tg-rg-SE1176-Ab-1/ GM-Tg-rg-SE1176-Ab-2Anti-Rat PCYOX1L monoclonal antibodyRat
GM-Tg-mg-SE1176-Ab-1/ GM-Tg-mg-SE1176-Ab-2Anti-Mouse PCYOX1L monoclonal antibodyMouse
GM-Tg-cynog-SE1176-Ab-1/ GM-Tg-cynog-SE1176-Ab-2Anti-Cynomolgus/ Rhesus macaque PCYOX1L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1176-Ab-1/ GM-Tg-felg-SE1176-Ab-2Anti-Feline PCYOX1L monoclonal antibodyFeline
GM-Tg-cang-SE1176-Ab-1/ GM-Tg-cang-SE1176-Ab-2Anti-Canine PCYOX1L monoclonal antibodyCanine
GM-Tg-bovg-SE1176-Ab-1/ GM-Tg-bovg-SE1176-Ab-2Anti-Bovine PCYOX1L monoclonal antibodyBovine
GM-Tg-equg-SE1176-Ab-1/ GM-Tg-equg-SE1176-Ab-2Anti-Equine PCYOX1L monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1176-Ab-1/ GM-Tg-hg-SE1176-Ab-2; GM-Tg-rg-SE1176-Ab-1/ GM-Tg-rg-SE1176-Ab-2;
GM-Tg-mg-SE1176-Ab-1/ GM-Tg-mg-SE1176-Ab-2; GM-Tg-cynog-SE1176-Ab-1/ GM-Tg-cynog-SE1176-Ab-2;
GM-Tg-felg-SE1176-Ab-1/ GM-Tg-felg-SE1176-Ab-2; GM-Tg-cang-SE1176-Ab-1/ GM-Tg-cang-SE1176-Ab-2;
GM-Tg-bovg-SE1176-Ab-1/ GM-Tg-bovg-SE1176-Ab-2; GM-Tg-equg-SE1176-Ab-1/ GM-Tg-equg-SE1176-Ab-2
Products NameAnti-PCYOX1L monoclonal antibody
Formatmab
Target NamePCYOX1L
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PCYOX1L benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1176-Ag-1Recombinant multi-species PCYXL/ PCYOX1L protein


    Target information

    Target IDGM-SE1176
    Target NamePCYOX1L
    Gene ID78991,240334,307396,710587,489194,101087969,514598,100060629
    Gene Symbol and SynonymsC630049M13,PCYOX1L,RGD1563290
    Uniprot AccessionQ8NBM8,Q0P5H1
    Uniprot Entry NamePCYXL_HUMAN,PCYXL_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000145882
    Target ClassificationN/A

    The target: PCYOX1L, gene name: PCYOX1L, also named as . Predicted to enable prenylcysteine oxidase activity. Predicted to be involved in prenylated protein catabolic process. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.